Product Information
DANTROLENE SODIUM 25 MG CAP is a generic product labeled by AvPAK, priced at $0.4088 per EA under NDC 50268021715. Its NADAC has been published 273 times since Jul 14, 2021.
FDA first approved this application on Mar 1, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
AvPAKNDC
50268021715
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DANTROLENE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076856FDA Approved
3/1/2005
TE Code
AB
On Market Since
3/9/2021
Pharmacological Classes
Price Statistics
The NADAC for DANTROLENE SODIUM 25 MG CAP has been published 273 times since Jul 14, 2021, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4088 per EA |
|---|---|
| All-time high | $0.5968 (Jan 10, 2024) |
| All-time low | $0.3106 (Aug 23, 2023) |
| 52-week high | $0.4545 |
| 52-week low | $0.3955 |
| Median price | $0.4224 |
| Average price | $0.4272 |
| Largest weekly change | +61.6% (Feb 22, 2023) |
| Weeks tracked | 273 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dantrolene Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Skeletal Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DANTROLENE SODIUM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DANTROLENE SODIUM 25 MG CAP, manufactured by AvPAK, is $0.4088 per EA (NDC 50268021715), effective Sep 30, 2026.
How has the price of DANTROLENE SODIUM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DANTROLENE SODIUM 25 MG CAP has risen 3.4%. It has been tracked across 273 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for DANTROLENE SODIUM 25 MG CAP?
Since Jul 14, 2021, the NADAC for DANTROLENE SODIUM 25 MG CAP has ranged from a low of $0.3106 (Aug 23, 2023) to a high of $0.5968 (Jan 10, 2024), with a median of $0.4224 per EA.
Are there cheaper alternatives to DANTROLENE SODIUM 25 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DANTROLENE SODIUM 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DANTROLENE SODIUM 25 MG CAP?
DANTROLENE SODIUM 25 MG CAP (NDC 50268021715) is labeled by AvPAK, and CMS classifies it as a generic product.